STAFX
Price
$46.01
Change
-$0.13 (-0.28%)
Updated
Dec 3 closing price
Net Assets
1.01B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

STAFX vs VIGRX

Header iconSTAFX vs VIGRX Comparison
Open Charts STAFX vs VIGRXBanner chart's image
Allspring Large Cap Growth A
Price$46.01
Change-$0.13 (-0.28%)
VolumeN/A
Net Assets1.01B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
STAFX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
STAFX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STAFX is a StrongBuy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. STAFX (1.01B). VIGRX pays higher dividends than STAFX: VIGRX (0.30) vs STAFX (0.00). STAFX was incepted earlier than VIGRX: STAFX (15 years) vs VIGRX (33 years). STAFX (1.18) is less costly to investors than VIGRX (0.17). STAFX is a more actively managed with annual turnover of: 44.00 vs. VIGRX (11.00). STAFX has a lower initial minimum investment than VIGRX: STAFX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. STAFX (-2.69). VIGRX return over 5 years is better than : 99.11 vs. STAFX (-15.76).
STAFXVIGRXSTAFX / VIGRX
Total Expense Ratio1.020.17600%
Annual Report Gross Expense Ratio1.180.17694%
Fund Existence15 years33 years-
Gain YTD15.89419.76480%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B357B0%
Annual Yield % from dividends0.000.30-
Returns for 1 year-2.6918.49-15%
Returns for 3 years27.66110.8225%
Returns for 5 years-15.7699.11-16%
Returns for 10 years-7.35349.13-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT